Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company’s lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. It has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

13

Address:

Brickell Biotech, Inc. 5777 Central Avenue Suite 102 Boulder CO 80301 United States

Website:

Home

Phone:

720-505-4755

Leave a comment

Your email address will not be published. Required fields are marked *